Idaho Perinatal Project

Urgent Recall on Similac Infant Formula

Affected (only produced in Sturgis, MI)

  • 12.6 oz Total Comfort powder
  • 12.5 oz Similac for Spit Up powder
  • All EleCare* powder Infant and Jr
  • All Alimentum* powder

Partially Affected (produced in Sturgis, MI as well as other plants)

  • 12.5 oz Similac Sensitive powder
  • 12.4 oz Similac Advance powder

Not Affected (not produced at Sturgis, MI plant)

  • Isomil
  • NeoSure
  • All concentrated liquids and ready to feeds

Perinatal Pulse Newsletter


Idaho Perinatal Project Mission

The primary purpose of the Idaho Perinatal Project is to reduce maternal and infant morbidity and mortality and to improve pregnancy outcomes throughout the state of Idaho.

Our goals include the creation of a database for maternal/child outcomes; correlate, analyze, and make recommendations regarding maternal/child statistical data for the state of Idaho; provide education to perinatal health care professionals and the general public; and become a main resource and advocate in maternal/infant health.

National Maternal Mental Health Hotline: 1-833-943-5746

Safe Haven

Crying Baby Resources


The Title V Maternal and Child Health (MCH) Block Grant Program is one of the largest federal block grant programs and the longest standing public health legislation with the goal of improving the health and well-being of mothers, infants, and children, including children and youth with special health care needs, and their families. Title V supports a spectrum of services, including infrastructure-building services such as quality assurance and policy development, and filling in gaps in direct health care services for children and youth with special health care needs.

Whether you are a parent, government official, advocate, service provider, or member of the general public, the Idaho MCH Block Grant likely touches you or a family member’s life. Its success lies in the strength of partnerships, collaborations, and involvement of Idaho families. The program collects input related to existing services and programs, population needs, and emerging issues to assure that the MCH Program is guided by the needs of Idaho. Each year, we invite the public to review and provide input on Idaho’s MCH Block Grant Application prior to submission.

Public comment is being accepted on the block grant application through July 24, 2020. To provide feedback on this year?s MCH Block Grant Executive Summary, please send an email to and include “MCH Grant” in the subject line.

To learn more about the Title V MCH Block Grant Program, please visit the Federal Title V Information System (TVIS) website which allows you to compare Idaho to other states:

Attention Idaho Nurses

Primary Health Medical Group has COVID vaccine available for healthcare workers. If you would like to receive the COVID vaccine at a Primary Health location, please follow the instructions below. Vaccine is also available for staff working in your offices.

  • If you are in Ada, Boise, Elmore or Valley county, please read the general/scheduling instructions here:
  • If you are in Adams, Canyon, Gem, Owyhee, Payette or Washington county, please read the general/scheduling instructions here:
  • If you are not in one of the counties listed above, you should contact your health district for further instructions; Primary Health is only authorized to vaccinate in the counties listed above.
  • Regardless of county location, all vaccine recipients should review certain documents prior to scheduling. Those documents can be reviewed here:

    PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTRY), a nationwide registry for pregnant and postpartum women with suspected COVID-19 or confirmed diagnosis.

    Click to visit PRIORITY website >>

    The aim of PRIORITY is to collect high yield data to answer urgent questions that inform care and counseling of pregnant women and their newborns.

    A collaborative group from the University of California San Francisco are leading the study.

    They are enrolling patients from any hospital across the country. Please consider referring patients and passing this information along to your colleagues and networks.

    TO REFER A PATIENT (Suspected/Under Investigation OR Confirmed Case, any language spoken): You do not need IRB or Research Ethics Board approval at your site because no research activities will occur there. Please ask the patient if she is willing to have her contact information shared. If yes, you can click here to Refer a Patient, or call/text 415-754-3729, or email at

    The patient can also contact then herself. For Patients: Enroll in PRIORITY . They will then reach out directly to her to consent, enroll, and begin data collection.

    Here are more details about the study procedures: Information for Providers. If you are willing, please circulate to your colleagues.

Latest News

Upcoming Events


15 Webinar: Harnessing the Power of Collaboration to Improve Outcomes for Families Affected by Substance Use Disorder in Pregnancy
Thursday | September 15, 2022 | 11:00am–Noon (PDT) / 2–3pm (EDT)
Register Online ››
View Flier ››
12:30 – 5 p.m. Mountain time
View Postcard ››
23 Idaho HPV Stakeholder Meeting
11am – 1:30pm
Jack's Urban Meeting Place
Register Onine ››

Online and On Demand

  The Intestinal Microbiome and the Developing Immune System
Archived Webcast—Video On Demand
Earn 1.0 hour CE/CME/CPEU credit
More info ››
  Global Guidelines for the Nutritional Care of Preterm Infants — On-Demand Course—Earn 1.5 CE/CME Credits
On Demand
More info ››